Issuer · CIK 0002114044
COAG — Hemab Therapeutics Holdings, Inc.
Recent filings
- Jun 17, 2026·Form 4·Buy$1.5M
COAG/Hemab Therapeutics Holdings, Inc.
RA CAPITAL MANAGEMENT, L.P. · director
28conviction - May 21, 2026·Form 4·Buy$94.9K
COAG/Hemab Therapeutics Holdings, Inc.
RA CAPITAL MANAGEMENT, L.P. · director
Mechanical filing
AI thesis skipped - May 14, 2026·Form 4·Buy$159K
COAG/Hemab Therapeutics Holdings, Inc.
RA CAPITAL MANAGEMENT, L.P. · director
18conviction - May 11, 2026·Form 4·Buy$643K
COAG/Hemab Therapeutics Holdings, Inc.
RA CAPITAL MANAGEMENT, L.P. · director
28conviction - May 6, 2026·Form 4·Buy$45.7M
COAG/Hemab Therapeutics Holdings, Inc.
RA CAPITAL MANAGEMENT, L.P. · director
58conviction - May 6, 2026·Form 4·Other—
COAG/Hemab Therapeutics Holdings, Inc.
Novo Holdings A/S · 10pct_owner
Mechanical filing
AI thesis skipped